In Crs.
PARTICULARS FY19 FY20 FY21 FY22 FY23
ASSETS
Non-current assets
Property, plant and equipment 1712 1725 1644 1707 1923
Capital work-in-progress 36 12 18 63 259
Right of use assets 0 237 200 169 131
Goodwill 66 58 58 58 117
Intangible assets 60 72 59 46 166
Intangible assets under development 20 0 2 4 0
Investment in associates 3 3 3 1 0
Financial assets
(i) Investments 14 14 8 1 1
(ii) Loans receivables 35 40 0 0 82
(iii) Other financial assets 0 1 38 44 56
Income tax assets (net) 65 97 44 64 39
Deferred tax assets 4 2 2 1 6
Other non-current assets 93 44 30 64 89
Total non-current assets 2110 2304 2105 2221 2868
Current assets
Inventories 83 60 48 59 72
Financial assets
(i) Investments 0 69 110 131 251
(ii) Trade receivables 266 262 279 437 432
(iii) Cash and cash equivalents 96 103 111 157 155
(iv) Bank balances other than (iii) above 4 12 21 15 225
(v) Loans receivables 3 8 0 0 0
(vi) Other financial assets 30 33 52 62 87
Other current assets 44 38 45 47 73
Total current assets 527 586 665 909 1294
TOTAL ASSETS 2637 2891 2770 3130 4162
EQUITY AND LIABILITIES
Equity
Equity share capital 204 204 204 204 204
Other Equity 877 932 916 1284 1927
Equity attributable to owners of the Company 1081 1136 1120 1489 2131
Non-controlling interests 0 1 1 1 1
Total equity 1082 1136 1121 1489 2132
Liabilities
Non-current liabilities
Financial liabilities
(i) Borrowings 725 619 504 432 626
(ii) Lease liabilities 0 201 169 135 89
(iii) Other financial liabilities 117 129 111 90 77
Provisions 16 20 25 30 35
Deferred tax liabilities 48 54 13 51 87
Other non-current liabilities 139 130 124 123 128
Total non-current liabilities 1045 1153 946 861 1042
Current liabilities
Financial liabilities
(i) Borrowings 12 11 114 113 136
(ii) Lease liabilities 0 33 38 44 33
(iii) Trade payables 334 362 410 449 615
(iv) Other financial liabilities 100 118 28 37 44
Provisions 27 33 30 39 48
Other current liabilities 39 45 83 97 107
Current Tax Liabilities ( Net ) 0 0 0 0 5
Total current liabilities 510 602 703 778 987
TOTAL EQUITY AND LIABILITIES 2637 2891 2770 3128 4162
FY24 FY25
2198
514
202
118
133
0
0
4
86
56
11
5
350
3678 0
110
840
422
264
153
0
90
68
1946 0
5625 0
204
2679
2884 0
1
2885 0
1195
150
63
41
47
133
1629 0
249
33
604
37
50
114
24
1110 0
5625 0
PARTICULARS FY19
Revenue from operations 2,861
Other income 17
Total income (A) 2,878
EXPENSES
Purchase of medical consumables, drugs and surgical instruments 687
Changes in inventories 0
Employee benefit expenses 623
Professional fees to doctors 591
Other expenses 672
Expenses before finance costs, depreciation and amortisation and exceptional items (B) 2,573
EBITDA (A-B) 304
Finance costs (C) 71
Depreciation and amortisation expense (D) 137
Total expenses (E) = (B+C+D) 2,782
Profit before exceptional items and tax (F) = (A-E) 96
Exceptional items (G) 0
Profit before share of (loss) of equity accounted investees and income tax (H) = (F+G) 96
Share of (loss) of equity accounted investees (I) (2)
Profit before tax (J) = (H+I) 93
Tax expense:
Current tax
- Current Year 24
- Prior Year 0
MAT credit entitlement (24)
Deferred tax charge / (credit) 34
Total tax expense (K) 34
Profit for the year (L) = (J-K) 59
Discontinued Operations
Profit before tax from discontinued operations 0
Tax expense of discontinued operations 0
Profit from discontinued operations after taxes (M) 0
Other comprehensive income (OCI)
Items that will not be reclassified subsequently to profit or loss
- Re-measurement of defined benefit plans (1)
- Income tax effect 0
Items that will be reclassified subsequently to profit or loss
- Effective portion of gains or (losses) in cashflow hedge (6)
- Effective portion of gains/(losses) of net investment hedge in a foreign operation (10)
- Exchange differences in translating the financial statements of a foreign operation 16
- Income tax relating to above items 1
Other comprehensive income / (loss) for the year, net of tax (M) (0)
Total comprehensive income for the year (N) = (L+M) 59
Earnings per share
- Basic (₹) 3
- Diluted (₹) 3
FY20 FY21 FY22 FY23 FY24 FY25
3,128 2,583 3,701 4,525 4,890
24 27 35 65 75
3,152 2,611 3,736 4,590 4,965 0
722 665 921 1,012 1,067
23 12 (12) (11) (37)
674 627 768 879 982
629 513 660 781 856
657 582 710 898 874
2,705 2,400 3,048 3,559 3,743 0
447 210 688 1,031 1,222 0
85 76 66 69 97
186 184 183 210 241
2,976 2,660 3,298 3,838 4,081 0
176 (49) 438 752 884 0
(11) 0 0 0 0
165 (49) 438 752 884 0
(3) (7) (9) 0 0
161 (56) 430 752 884 0
43 0 50 140 137
(2) 0 0 0 0
(4) (0) 0 0 0
5 (42) 38 5 (39)
42 (42) 88 145 98 0
119 (14) 342 607 786 0
0 0 0 0 5
0 0 0 0 (1)
0 0 0 0 4 0
(1) (1) (4) (6) (3)
(0) 0 1 2 1
(16) 8 14 6 (1)
(13) 4 (3) (8) 1
32 (12) 21 64 17
2 (1) (2) (1) 0
4 (2) 26 57 14 0
124 (16) 368 664 804 0
6 (1) 17 30 39
6 (1) 17 30 39
PARTICULARS FY19
Cash flow from operating activities
Profit after tax 59
Adjustments :
Income tax expense 34
Depreciation and amortisation expense 137
Interest income (2)
Interest income from financial asset at amortised cost (2)
Provision for loss allowance 11
Bad receivables written off 7
Gain on Derecognition of Financial Liability 0
Provision of inventories for write-down to net realisable value 6
Net loss from financial asset at amortised cost 0
Right to use building 2
Finance costs 71
Share based payment expenses / (reversed) (1)
Government grant income (4)
Provision for impairment of investment 1
Loss on sale/disposal of Property, plant and equipment 3
Profit on sale of investment (0)
Exceptional items (refer note 45) 0
Unrealised foreign exchange loss, net (1)
Share of loss of equity accounted investees 2
Liabilities/Provision no longer requirwed written back 0
Operating cash flow before working capital changes 324
Changes in trade receivables (5)
Changes in inventories (6)
Changes in loans, other financial assets and other assets 3
Changes in trade payables, other financial liabilities and other liabilities 13
Changes in provision 3
Cash generated from operations 333
Income tax paid (net of refund) (54)
Net cash generated from operating activities (A) 279
Cash flow from investing activities
Acquisition of property, plant and equipment (including capital work-in-progress) (150)
Proceeds from sale of property, plant and equipment 0
Investment In optionally Convertible Debentures 0
Payment Made Towards the Acquisition Of Shiva & Shiva Ortho Hospital 0
Investment for Acquisition Of Subsidiary 0
Purchase of Investments 0
Proceeds from sale of investments 0
Purchase of mutual fund (265)
Proceeds from sale of mutual fund 265
Investment in promissory note in an associate (10)
Investment in bank deposit (7)
Realisation of bank deposit 5
Interest received 1
Buy Back of Equity of an Associate 0
Net cash (used in) investing activities (B) (161)
Cash flow from financing activities
Proceeds from long-term borrowings 558
Repayment of long-term borrowings (530)
Dividend paid 0
Proceeds from exercise of share options 0
Interest and other borrowing costs (55)
Payment of lease liabilities 0
Net cash (used in) financing activities (C) (27)
Net increase / (decrease) in cash and cash equivalents (A+B+C) 90
Cash and cash equivalents at the beginning of the year (5)
Effects of exchange gain on restatement of foreign currency cash and cash equivalents (1)
Cash and cash equivalents at the end of the year 84
FY20 FY21 FY22 FY23 FY24 FY25
119 (14) 342 607
42 (42) 88 145
186 184 183 210
(2) (10) (2) (10)
(2) (4) (6) (5)
14 (5) 11 26
1 3 7 0
0 0 0 (16)
0 0 0 0
0 1 6 0
2 2 1 1
85 76 66 69
3 1 0 0
(6) (6) (7) (8)
1 0 0 0
6 5 3 7
(2) 0 (0) 1
11 0 0 0
(4) (4) 11 39
3 7 9 0
0 0 (9) (1)
456 194 703 1,065 0 0
(11) (15) (176) (14)
23 12 (12) (12)
44 (3) (19) (8)
(13) 60 45 129
10 2 11 10
509 251 552 1,170 0 0
(66) 54 (67) (86)
443 304 485 1,085 0 0
(116) (70) (251) (522)
1 0 0 1
0 0 (1) (80)
0 0 0 (200)
0 0 0 (43)
(1) 0 0 (310)
1 0 0 189
(746) (42) (57) 0
678 0 30 0
0 0 0 0
(11) (16) (12) (293)
4 6 19 76
1 8 1 8
0 0 3 0
(189) (113) (267) (1,174) 0 0
43 12 67 277
(151) (114) (135) (68)
(49) 0 0 (20)
0 0 0 0
(51) (43) (36) (43)
(39) (48) (55) (57)
(247) (194) (159) 88 0 0
8 (2) 59 (2) 0 0
84 92 90 149
(0) 0 (0) (2)
92 90 148 145 0 0